Clínica Baviera, S.A. (BME:CBAV)
Spain · Delayed Price · Currency is EUR 44.40
+0.20 (0.45%)
Sep 11, 2025, 5:35 PM CET
Clínica Baviera Market Cap
Clínica Baviera has a market cap or net worth of €722.75 million as of September 11, 2025. Its market cap has increased by 45.84% in one year.
Market Cap
722.75M
Enterprise Value
748.98M
Revenue
288.92M
Ranking
n/a
PE Ratio
18.51
Stock Price
€44.40
Market Cap Chart
Since April 10, 2007, Clínica Baviera's market cap has increased from 369.53M to 722.75M, an increase of 95.59%. That is a compound annual growth rate of 3.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 719.49M | 44.25% |
| Dec 31, 2024 | 498.78M | 33.02% |
| Dec 29, 2023 | 374.97M | 31.81% |
| Dec 30, 2022 | 284.48M | -17.68% |
| Dec 30, 2021 | 345.60M | 50.35% |
| Dec 31, 2020 | 229.87M | -1.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 7.48B |
| Laboratorios Farmaceuticos Rovi | 3.05B |
| Almirall | 2.38B |
| Pharma Mar | 1.55B |
| Faes Farma | 1.33B |
| Laboratorio Reig Jofre | 235.19M |
| Oryzon Genomics | 215.49M |
| Atrys Health | 214.85M |